# Run `20261022-010102-round-2-of-the-b7-h3-cd276-case-76d40ca3`

> Round 2 of the B7-H3 (CD276) case study was interrupted mid-execution by a transient API connection error, not a data or code problem. Before doing anything else, read this resume file in full: /mnt/beegfs/xqinag/projects/TheVirtualBiotech/runs/b7h3_round2_20261021/config/resume_after_interruption_4.md -- it tells you exactly what is already done and verified (reuse directly, do not redo), what was in progress when the interruption hit (verify what exists on disk, resume rather than restart), and what has not started yet. The original scope/rules file is still at /mnt/beegfs/xqinag/projects/TheVirtualBiotech/runs/b7h3_round2_20261021/config/full_requirements.md if you need to check any detail not covered in the resume file. State briefly that you have read the resume file, then continue execution: finish Wave 2 (LIANA 4D/S5A, cell2location 4E/S5B), then proceed through the spatial-neighborhood analysis, the scientific-reviewer pass (checking underlying data/scripts/figures directly, not just report prose), and final synthesis. No approval checkpoint needed this time -- proceed straight through to delivery.

| | |
|---|---|
| **Status** | incomplete |
| **Started** | 2026-10-22T01:01:02.745481 |
| **Duration** | 8.3 min |
| **Specialists** | 5 |
| **Artifacts** | 24 (304.4 KB) |
| **Tool calls** | 76 (0 by specialists, 76 by the CSO) |
| **Tool errors** | 1 |
| **Claims** | 15 |
| **Evidence coverage** | incomplete |

> **Evidence audit incomplete.** File hashes alone do not establish that the report's conclusions have recorded support.

- The final report contains no claim references, so its conclusions are not linked to the recorded evidence.
- Research turn 1 has no valid claim references; an earlier turn's citations do not cover its findings.

Evidence coverage checks recorded pointers and report references; it does not verify scientific correctness or external citations. Use `verify` below to also check artifact hashes.

> **Misplaced files.** These were written into directories the run harness owns, where analysis output does not belong. They are not recorded as artifacts and nothing can cite them; whichever agent produced them should have written under `work/<agent>/`.

> - `report/panel_by_paper_comparison.md`
> - `report/workflow_diagram.svg`
> - `report/README_update_proposed.md`

## What each agent produced

### Clinical Trialist  ·  3 artifacts

| File | Kind | Size | Produced by | Cited by |
|---|---|---|---|---|
| `work/clinical-trialist/results/reports/tcga_luad_cd276_survival_report.md` | report | 12.9 KB | — | C113, C114, C115 |
| `work/clinical-trialist/results/tables/tcga_luad_cd276_cox_models.csv` | table | 16.7 KB | — | C113, C114 |
| `work/clinical-trialist/results/tables/tcga_luad_cohort_construction.csv` | table | 1.4 KB | — | C115 |

### Functional Genomics Analyst  ·  4 artifacts

| File | Kind | Size | Produced by | Cited by |
|---|---|---|---|---|
| `work/functional-genomics-analyst/results/reports/tahoe_round2_status.md` | report | 15.5 KB | — | C116, C117 |
| `work/functional-genomics-analyst/results/tables/round1_depmap_recomputed_group_summary.csv` | table | 855 B | — | C117 |
| `work/functional-genomics-analyst/results/tables/round1_depmap_verification.csv` | table | 3.2 KB | — | C117 |
| `work/functional-genomics-analyst/results/tables/tahoe_round2_attempt_log.csv` | table | 4.9 KB | — | C116 |

### Genomics Analyst  ·  3 artifacts

| File | Kind | Size | Produced by | Cited by |
|---|---|---|---|---|
| `work/genomics-analyst/results/reports/cd276_panel4a_report.md` | report | 28.2 KB | — | C101, C103 |
| `work/genomics-analyst/results/tables/cd276_e2g_within_window_score_distance_summary.csv` | table | 2.2 KB | — | C103 |
| `work/genomics-analyst/results/tables/cd276_round2_germline_verification.csv` | table | 3.9 KB | — | C101 |

### Scientific Reviewer  ·  2 artifacts

| File | Kind | Size | Produced by | Cited by |
|---|---|---|---|---|
| `work/scientific-reviewer/results/reports/review_round2_full.md` | report | 39.3 KB | — | C118 |
| `work/scientific-reviewer/results/reports/review_round2_rereview.md` | report | 27.9 KB | — | C118 |

### Single Cell Analyst  ·  12 artifacts

| File | Kind | Size | Produced by | Cited by |
|---|---|---|---|---|
| `work/single-cell-analyst/results/reports/liana_panels4d_s5a_report.md` | report | 37.0 KB | — | C107 |
| `work/single-cell-analyst/results/reports/scrna_panels4bc_report.md` | report | 11.8 KB | — | C104, C105, C111 |
| `work/single-cell-analyst/results/reports/visium_c2l_panels4e_s5b_report.md` | report | 44.8 KB | — | C109, C110, C112 |
| `work/single-cell-analyst/results/reports/visium_ingest_qc_log.md` | report | 13.4 KB | — | — |
| `work/single-cell-analyst/results/tables/liana_caf_depth_audit.csv` | table | 751 B | — | C107 |
| `work/single-cell-analyst/results/tables/liana_top_differential_pairs.csv` | table | 10.0 KB | — | C107 |
| `work/single-cell-analyst/results/tables/scrna_cd276_de_summary.csv` | table | 2.5 KB | — | C105 |
| `work/single-cell-analyst/results/tables/scrna_cd276_expression_by_celltype.csv` | table | 4.0 KB | — | C111 |
| `work/single-cell-analyst/results/tables/scrna_cell_donor_audit.csv` | table | 3.7 KB | — | C104 |
| `work/single-cell-analyst/results/tables/visium_c2l_cd276_stratification_audit.csv` | table | 5.0 KB | — | C112 |
| `work/single-cell-analyst/results/tables/visium_neighborhood_composition_pp_difference.csv` | table | 13.0 KB | — | C109 |
| `work/single-cell-analyst/results/tables/visium_neighborhood_edge_spot_sensitivity.csv` | table | 1.7 KB | — | C110 |

## Claims and their evidence

### [✓] `C101` — No LUAD or SCLC GWAS credible set and no L2G locus supports CD276: 0 of 8 studies carry a credible set within ±500 kb of the CD276 locus, and 0 of 67 L2G predictions derive from a LUAD or SCLC study.

*Genomics Analyst · confidence: strong*

- **table** `work/genomics-analyst/results/tables/cd276_round2_germline_verification.csv` — per-study credible-set and L2G verification; all counts zero  ·  _✓ verified_
- **artifact** `work/genomics-analyst/results/reports/cd276_panel4a_report.md` — Panel 4A germline section  ·  _✓ verified_

### [✓] `C103` — ENCODE lung rE2G predicts 839 CD276-linked regulatory elements genome-wide, of which 77 lie within ±500 kb of the TSS (median 241.1 kb), 29 reach the pre-declared Score ≥ 0.02 threshold, and the top element is the CD276 promoter (Score 0.973).

*Genomics Analyst · confidence: strong*

- **table** `work/genomics-analyst/results/tables/cd276_e2g_within_window_score_distance_summary.csv` — element counts by window and score threshold; top element row  ·  _✓ verified_
- **artifact** `work/genomics-analyst/results/reports/cd276_panel4a_report.md` — Panel 4A regulatory section and threshold rationale  ·  _✓ verified_

### [✓] `C104` — The rebuilt LUAD/SCLC single-cell atlas contains 413,996 cells, 80 donors and 15 cell types after the paper's QC filters and donor-stratified downsampling.

*Single Cell Analyst · confidence: strong*

- **table** `work/single-cell-analyst/results/tables/scrna_cell_donor_audit.csv` — cell, donor and cell-type totals after QC  ·  _✓ verified_
- **artifact** `work/single-cell-analyst/results/reports/scrna_panels4bc_report.md` — Panels 4B/4C atlas construction  ·  _✓ verified_

### [✓] `C105` — CD276 is not significantly differentially expressed in any of 15 primary disease-vs-normal pseudobulk contrasts; the smallest adjusted p-value is 0.291 (SCLC macrophage, log2FC −0.95).

*Single Cell Analyst · confidence: strong*

- **table** `work/single-cell-analyst/results/tables/scrna_cd276_de_summary.csv` — 15 contrast rows with log2FC and padj  ·  _✓ verified_
- **artifact** `work/single-cell-analyst/results/reports/scrna_panels4bc_report.md` — Panels 4B/4C differential-expression section  ·  _✓ verified_

### [✓] `C107` — LIANA shows no interaction unique to CD276-high CAFs: most calls are shared between high and low groups, there is no formal between-group test or FDR, the detection split carries a 55–69% detected-gene depth gap, and the high group is myCAF-marker-enriched (1.43 vs 1.00, donor paired p = 4.8e-7).

*Single Cell Analyst · confidence: moderate*

- **table** `work/single-cell-analyst/results/tables/liana_top_differential_pairs.csv` — high/low call counts and recurring ECM/proteolysis pairs  ·  _✓ verified_
- **table** `work/single-cell-analyst/results/tables/liana_caf_depth_audit.csv` — detected-gene depth gap and myCAF marker score by group  ·  _✓ verified_
- **artifact** `work/single-cell-analyst/results/reports/liana_panels4d_s5a_report.md` — Panels 4D/S5A interpretation and donor support  ·  _✓ verified_

### [✓] `C109` — The depth-robust Visium composition difference around high-CD276 tumour spots is malignant enrichment of +3.79 percentage points (12/12 sections, 5/5 donors) with donor-concordant depletion of endothelium (−2.03 pp), NK cells (−0.49 pp) and macrophages (−0.40 pp); T-cell fraction changes by only +0.11 pp.

*Single Cell Analyst · confidence: moderate*

- **table** `work/single-cell-analyst/results/tables/visium_neighborhood_composition_pp_difference.csv` — per-cell-type percentage-point differences with section and donor concordance  ·  _✓ verified_
- **artifact** `work/single-cell-analyst/results/reports/visium_c2l_panels4e_s5b_report.md` — Panels 4E/S5B composition analysis  ·  _✓ verified_

### [✓] `C110` — The Visium immune-hot signal occurs only in absolute abundance and is confounded: tumour high-CD276 spots have a 2.03x median-of-medians capture-depth difference (7,545.0 vs 3,708.5), and the abundance difference does not survive restriction to interior spots.

*Single Cell Analyst · confidence: moderate*

- **table** `work/single-cell-analyst/results/tables/visium_neighborhood_edge_spot_sensitivity.csv` — edge-vs-interior sensitivity results  ·  _✓ verified_
- **artifact** `work/single-cell-analyst/results/reports/visium_c2l_panels4e_s5b_report.md` — Panels 4E/S5B depth and edge-effect audit  ·  _✓ verified_

### [✓] `C111` — CD276 detection is highest in LUAD fibroblasts (30.84% of 3,411 cells), SCLC fibroblasts (35.3% of 244 cells) and normal lung macrophages (36.53% of 3,011 cells), so CD276 is not tumour-restricted.

*Single Cell Analyst · confidence: strong*

- **table** `work/single-cell-analyst/results/tables/scrna_cd276_expression_by_celltype.csv` — detection percentage and mean expression per cell type  ·  _✓ verified_
- **artifact** `work/single-cell-analyst/results/reports/scrna_panels4bc_report.md` — Panels 4B/4C detection analysis  ·  _✓ verified_

### [✓] `C112` — Visium CD276 stratification is detection-based rather than expression-quantile: the low group is the CD276-zero tail, the adjacent-normal high group is degenerate (median CD276 = 0.0 in 8 of 10 sections), and the rank fallback fires in 22 of 22 sections.

*Single Cell Analyst · confidence: strong*

- **table** `work/single-cell-analyst/results/tables/visium_c2l_cd276_stratification_audit.csv` — per-section group medians and fallback flags  ·  _✓ verified_
- **artifact** `work/single-cell-analyst/results/reports/visium_c2l_panels4e_s5b_report.md` — Panels 4E/S5B stratification audit  ·  _✓ verified_

### [✓] `C113` — In TCGA LUAD, unadjusted Q4-vs-Q1 CD276 expression is associated with worse overall survival (HR 1.80, 95% CI 1.19–2.71, p = 0.0051) and disease-specific survival (HR 1.86, 95% CI 1.10–3.13, p = 0.0206).

*Clinical Trialist · confidence: strong*

- **table** `work/clinical-trialist/results/tables/tcga_luad_cd276_cox_models.csv` — unadjusted Q4-vs-Q1 OS and DSS model rows  ·  _✓ verified_
- **artifact** `work/clinical-trialist/results/reports/tcga_luad_cd276_survival_report.md` — Panel 4F unadjusted models  ·  _✓ verified_

### [✓] `C114` — After adjustment for age, stage and sex, the CD276 survival association in TCGA LUAD is not significant: adjusted OS HR 1.44 (p = 0.106) and adjusted DSS HR 1.39 (p = 0.249), so CD276 is not an independent prognostic factor in this cohort on this analysis.

*Clinical Trialist · confidence: strong*

- **table** `work/clinical-trialist/results/tables/tcga_luad_cd276_cox_models.csv` — adjusted OS and DSS model rows  ·  _✓ verified_
- **artifact** `work/clinical-trialist/results/reports/tcga_luad_cd276_survival_report.md` — Panel 4F adjusted models and PH diagnostics  ·  _✓ verified_

### [✓] `C115` — The TCGA LUAD cohort has 566 patients, of whom 510 have CD276 mRNA; 251 samples enter the unadjusted Q4-vs-Q1 contrast and 246 enter the adjusted model.

*Clinical Trialist · confidence: strong*

- **table** `work/clinical-trialist/results/tables/tcga_luad_cohort_construction.csv` — cohort funnel: 566 enrolled, 510 with expression, 251/246 analysis sets  ·  _✓ verified_
- **artifact** `work/clinical-trialist/results/reports/tcga_luad_cd276_survival_report.md` — Panel 4F cohort construction  ·  _✓ verified_

### [✓] `C116` — The Tahoe-100M differential-expression track is blocked and therefore not assessable: all three perturbation calls failed with 'TAHOE_DATA_PATH not set in environment' before reading data, and no evidence of absence or non-materiality can be inferred.

*Functional Genomics Analyst · confidence: strong*

- **table** `work/functional-genomics-analyst/results/tables/tahoe_round2_attempt_log.csv` — three logged attempts and exact errors  ·  _✓ verified_
- **artifact** `work/functional-genomics-analyst/results/reports/tahoe_round2_status.md` — Tahoe/DepMap status report  ·  _✓ verified_

### [✓] `C117` — CD276 is not essential in cancer cell lines: mean gene effect is −0.230 in LUAD (n = 46, 1/46 below the −0.5 threshold) and −0.204 in SCLC (n = 25, 0/25 below threshold), with round-1 DepMap artifacts re-verified 54/54.

*Functional Genomics Analyst · confidence: strong*

- **table** `work/functional-genomics-analyst/results/tables/round1_depmap_recomputed_group_summary.csv` — mean gene effect and essential fraction by histology  ·  _✓ verified_
- **table** `work/functional-genomics-analyst/results/tables/round1_depmap_verification.csv` — 54/54 artifact re-verification  ·  _✓ verified_
- **artifact** `work/functional-genomics-analyst/results/reports/tahoe_round2_status.md` — DepMap section  ·  _✓ verified_

### [✓] `C118` — The scientific reviewer's final verdict is ACCEPT WITH DISCLOSED LIMITATIONS, with both acceptance conditions (deleting leftover history CSV stubs and recomputing four median-of-medians values) verified as resolved without re-analysis.

*Scientific Reviewer · confidence: strong*

- **artifact** `work/scientific-reviewer/results/reports/review_round2_rereview.md` — final verdict and condition-resolution checks  ·  _✓ verified_
- **artifact** `work/scientific-reviewer/results/reports/review_round2_full.md` — first full pass with 20 items  ·  _✓ verified_

## Reproducing this run

```bash
./run.sh verify 20261022-010102-round-2-of-the-b7-h3-cd276-case-76d40ca3   # check file hashes and evidence coverage
./run.sh verify 20261022-010102-round-2-of-the-b7-h3-cd276-case-76d40ca3 --rerun   # also re-execute analysis scripts
./run.sh replay 20261022-010102-round-2-of-the-b7-h3-cd276-case-76d40ca3   # re-run the same turns into a new run dir
```

`verify` checks recorded files, claims and report references. With `--rerun`, it also re-executes the analysis scripts under `work/*/code/` and compares the reproduced outputs. `replay` re-runs the agents against the same pinned models and prompts — LLM sampling means it is comparable, not bit-identical.

<details><summary>Pinned configuration</summary>

```json
{
  "session_id": "40c1ab95-dacb-426c-abd9-4bb60906c5c8",
  "cso_model": "claude-sonnet-4-5-20250929",
  "specialist_model": "claude-sonnet-4-5-20250929",
  "specialist_model_label": "claude-sonnet-4-5-20250929",
  "effort": "xhigh",
  "max_turns": 100,
  "python": "3.11.17",
  "host": "n1",
  "started": "2026-10-22T01:01:02.677279",
  "interface": "web_or_batch",
  "audit_required": true,
  "claude_agent_sdk": "0.1.69",
  "git_commit": "71f9da68c95c5ee0ef4c1d9b8f45f10693de022d",
  "prompt_sha256": {
    "chief_of_staff/system_prompt.md": "8bcdef74c90cc045",
    "cso/system_prompt.md": "ce111aaf81408dc1",
    "modality_selection/system_prompts/medchem_pharmacologist_short.md": "73c865ec6f1c745d",
    "modality_selection/system_prompts/target_biologist_short.md": "e2be1776d719164f",
    "safety/system_prompts/bio_pathways_ppi_analyst_short.md": "f00ec50864bc9caf",
    "safety/system_prompts/clinical_trialist_short.md": "c0403869a6bd312a",
    "safety/system_prompts/fda_safety_officer_short.md": "415e8d0d20f96b6d",
    "scientific_reviewer/system_prompt.md": "0858303b50d034ed",
    "target_id/system_prompts/functional_genomics_analyst_short.md": "a8ddac7f120e5e01",
    "target_id/system_prompts/genomics_analyst_short.md": "ddc34ab89d5f1f84",
    "target_id/system_prompts/single_cell_analyst_short.md": "5485dce25d3ebf3e",
    "trial_matching/system_prompt.md": "6b9620e4d034229a"
  },
  "mcp_servers": [
    "association",
    "clinicaltrials",
    "disease",
    "drug",
    "expression",
    "functional_genomics",
    "genetics",
    "interaction",
    "pathway",
    "provenance",
    "single_cell",
    "target"
  ],
  "research_turns": [
    1
  ],
  "total_cost_usd": 4.333052,
  "num_turns": 1,
  "interrupted_turns": [],
  "data_source_errors": []
}
```

</details>

## Directory layout

```
MANIFEST.json   every artifact: hash, producing agent, producing tool call
inputs/         the query, the analysis plan, the pinned config
work/<agent>/   per-agent outputs — code/, data/, results/
evidence/       claims.json (claim → evidence), provenance.json (tool → agent)
logs/           trace.jsonl, cost_report.json, transcript.md
report/         the CSO's final synthesis
```

*Generated 2026-10-22 01:09:22 by `src/utils/run_report.py`.*